Charah Solutions, Inc.
Charah Solutions, Inc. (CHRA) Stock Competitors & Peer Comparison
See (CHRA) competitors and their performances in Stock Market.
Peer Comparison Table: Waste Management Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| CHRA | $5.96 | +0.17% | 20.3M | -0.15 | -$38.80 | N/A |
| WM | $224.49 | -1.47% | 90.2B | 32.54 | $6.90 | +1.52% |
| RSG | $203.88 | -1.29% | 63B | 29.72 | $6.86 | +1.20% |
| WCN | $157.66 | -1.84% | 40.1B | 38.45 | $4.10 | +0.84% |
| GFLU | $70.30 | +4.32% | 25B | -91.90 | -$0.77 | N/A |
| CLH | $313.70 | +1.05% | 16.7B | 42.96 | $7.30 | N/A |
| GFL | $36.99 | -1.91% | 12.8B | 99.89 | $0.37 | +0.17% |
| SRCL | $61.98 | +0.83% | 5.8B | 158.92 | $0.39 | N/A |
| CWST | $86.76 | +0.42% | 5.4B | 722.67 | $0.12 | N/A |
| NVRI | $19.39 | +1.20% | 1.6B | -9.55 | -$2.03 | N/A |
Stock Comparison
CHRA vs WM Comparison May 2026
CHRA plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHRA stands at 20.3M. In comparison, WM has a market cap of 90.2B. Regarding current trading prices, CHRA is priced at $5.96, while WM trades at $224.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHRA currently has a P/E ratio of -0.15, whereas WM's P/E ratio is 32.54. In terms of profitability, CHRA's ROE is +20.59%, compared to WM's ROE of +0.29%. Regarding short-term risk, CHRA is less volatile compared to WM. This indicates potentially lower risk in terms of short-term price fluctuations for CHRA.Check WM's competition here
CHRA vs RSG Comparison May 2026
CHRA plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHRA stands at 20.3M. In comparison, RSG has a market cap of 63B. Regarding current trading prices, CHRA is priced at $5.96, while RSG trades at $203.88.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHRA currently has a P/E ratio of -0.15, whereas RSG's P/E ratio is 29.72. In terms of profitability, CHRA's ROE is +20.59%, compared to RSG's ROE of +0.18%. Regarding short-term risk, CHRA is less volatile compared to RSG. This indicates potentially lower risk in terms of short-term price fluctuations for CHRA.Check RSG's competition here
CHRA vs WCN Comparison May 2026
CHRA plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHRA stands at 20.3M. In comparison, WCN has a market cap of 40.1B. Regarding current trading prices, CHRA is priced at $5.96, while WCN trades at $157.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHRA currently has a P/E ratio of -0.15, whereas WCN's P/E ratio is 38.45. In terms of profitability, CHRA's ROE is +20.59%, compared to WCN's ROE of +0.13%. Regarding short-term risk, CHRA is less volatile compared to WCN. This indicates potentially lower risk in terms of short-term price fluctuations for CHRA.Check WCN's competition here
CHRA vs GFLU Comparison May 2026
CHRA plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHRA stands at 20.3M. In comparison, GFLU has a market cap of 25B. Regarding current trading prices, CHRA is priced at $5.96, while GFLU trades at $70.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHRA currently has a P/E ratio of -0.15, whereas GFLU's P/E ratio is -91.90. In terms of profitability, CHRA's ROE is +20.59%, compared to GFLU's ROE of N/A. Regarding short-term risk, CHRA is less volatile compared to GFLU. This indicates potentially lower risk in terms of short-term price fluctuations for CHRA.Check GFLU's competition here
CHRA vs CLH Comparison May 2026
CHRA plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHRA stands at 20.3M. In comparison, CLH has a market cap of 16.7B. Regarding current trading prices, CHRA is priced at $5.96, while CLH trades at $313.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHRA currently has a P/E ratio of -0.15, whereas CLH's P/E ratio is 42.96. In terms of profitability, CHRA's ROE is +20.59%, compared to CLH's ROE of +0.14%. Regarding short-term risk, CHRA is less volatile compared to CLH. This indicates potentially lower risk in terms of short-term price fluctuations for CHRA.Check CLH's competition here
CHRA vs GFL Comparison May 2026
CHRA plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHRA stands at 20.3M. In comparison, GFL has a market cap of 12.8B. Regarding current trading prices, CHRA is priced at $5.96, while GFL trades at $36.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHRA currently has a P/E ratio of -0.15, whereas GFL's P/E ratio is 99.89. In terms of profitability, CHRA's ROE is +20.59%, compared to GFL's ROE of +0.03%. Regarding short-term risk, CHRA is less volatile compared to GFL. This indicates potentially lower risk in terms of short-term price fluctuations for CHRA.Check GFL's competition here
CHRA vs SRCL Comparison May 2026
CHRA plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHRA stands at 20.3M. In comparison, SRCL has a market cap of 5.8B. Regarding current trading prices, CHRA is priced at $5.96, while SRCL trades at $61.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHRA currently has a P/E ratio of -0.15, whereas SRCL's P/E ratio is 158.92. In terms of profitability, CHRA's ROE is +20.59%, compared to SRCL's ROE of -0.01%. Regarding short-term risk, CHRA is less volatile compared to SRCL. This indicates potentially lower risk in terms of short-term price fluctuations for CHRA.Check SRCL's competition here
CHRA vs CWST Comparison May 2026
CHRA plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHRA stands at 20.3M. In comparison, CWST has a market cap of 5.4B. Regarding current trading prices, CHRA is priced at $5.96, while CWST trades at $86.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHRA currently has a P/E ratio of -0.15, whereas CWST's P/E ratio is 722.67. In terms of profitability, CHRA's ROE is +20.59%, compared to CWST's ROE of +0.00%. Regarding short-term risk, CHRA is less volatile compared to CWST. This indicates potentially lower risk in terms of short-term price fluctuations for CHRA.Check CWST's competition here
CHRA vs NVRI Comparison May 2026
CHRA plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHRA stands at 20.3M. In comparison, NVRI has a market cap of 1.6B. Regarding current trading prices, CHRA is priced at $5.96, while NVRI trades at $19.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHRA currently has a P/E ratio of -0.15, whereas NVRI's P/E ratio is -9.55. In terms of profitability, CHRA's ROE is +20.59%, compared to NVRI's ROE of -0.49%. Regarding short-term risk, CHRA is less volatile compared to NVRI. This indicates potentially lower risk in terms of short-term price fluctuations for CHRA.Check NVRI's competition here
CHRA vs HCCI Comparison May 2026
CHRA plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHRA stands at 20.3M. In comparison, HCCI has a market cap of 1.1B. Regarding current trading prices, CHRA is priced at $5.96, while HCCI trades at $45.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHRA currently has a P/E ratio of -0.15, whereas HCCI's P/E ratio is 14.22. In terms of profitability, CHRA's ROE is +20.59%, compared to HCCI's ROE of +0.22%. Regarding short-term risk, CHRA is less volatile compared to HCCI. This indicates potentially lower risk in terms of short-term price fluctuations for CHRA.Check HCCI's competition here
CHRA vs MEG Comparison May 2026
CHRA plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHRA stands at 20.3M. In comparison, MEG has a market cap of 771.5M. Regarding current trading prices, CHRA is priced at $5.96, while MEG trades at $21.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHRA currently has a P/E ratio of -0.15, whereas MEG's P/E ratio is -164.08. In terms of profitability, CHRA's ROE is +20.59%, compared to MEG's ROE of -0.00%. Regarding short-term risk, CHRA is less volatile compared to MEG. This indicates potentially lower risk in terms of short-term price fluctuations for CHRA.Check MEG's competition here
CHRA vs HSC Comparison May 2026
CHRA plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHRA stands at 20.3M. In comparison, HSC has a market cap of 729.6M. Regarding current trading prices, CHRA is priced at $5.96, while HSC trades at $9.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHRA currently has a P/E ratio of -0.15, whereas HSC's P/E ratio is -5.08. In terms of profitability, CHRA's ROE is +20.59%, compared to HSC's ROE of -0.49%. Regarding short-term risk, CHRA is less volatile compared to HSC. This indicates potentially lower risk in terms of short-term price fluctuations for CHRA.Check HSC's competition here
CHRA vs PESI Comparison May 2026
CHRA plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHRA stands at 20.3M. In comparison, PESI has a market cap of 239.8M. Regarding current trading prices, CHRA is priced at $5.96, while PESI trades at $12.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHRA currently has a P/E ratio of -0.15, whereas PESI's P/E ratio is -22.29. In terms of profitability, CHRA's ROE is +20.59%, compared to PESI's ROE of -0.25%. Regarding short-term risk, CHRA is less volatile compared to PESI. This indicates potentially lower risk in terms of short-term price fluctuations for CHRA.Check PESI's competition here
CHRA vs YDDL Comparison May 2026
CHRA plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHRA stands at 20.3M. In comparison, YDDL has a market cap of 218.8M. Regarding current trading prices, CHRA is priced at $5.96, while YDDL trades at $4.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHRA currently has a P/E ratio of -0.15, whereas YDDL's P/E ratio is 21.72. In terms of profitability, CHRA's ROE is +20.59%, compared to YDDL's ROE of +0.36%. Regarding short-term risk, CHRA is less volatile compared to YDDL. This indicates potentially lower risk in terms of short-term price fluctuations for CHRA.Check YDDL's competition here
CHRA vs ESGL Comparison May 2026
CHRA plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHRA stands at 20.3M. In comparison, ESGL has a market cap of 136.9M. Regarding current trading prices, CHRA is priced at $5.96, while ESGL trades at $3.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHRA currently has a P/E ratio of -0.15, whereas ESGL's P/E ratio is -53.83. In terms of profitability, CHRA's ROE is +20.59%, compared to ESGL's ROE of -0.06%. Regarding short-term risk, CHRA is less volatile compared to ESGL. This indicates potentially lower risk in terms of short-term price fluctuations for CHRA.Check ESGL's competition here
CHRA vs LNZA Comparison May 2026
CHRA plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHRA stands at 20.3M. In comparison, LNZA has a market cap of 49.9M. Regarding current trading prices, CHRA is priced at $5.96, while LNZA trades at $22.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHRA currently has a P/E ratio of -0.15, whereas LNZA's P/E ratio is -1.02. In terms of profitability, CHRA's ROE is +20.59%, compared to LNZA's ROE of +5.56%. Regarding short-term risk, CHRA is less volatile compared to LNZA. This indicates potentially lower risk in terms of short-term price fluctuations for CHRA.Check LNZA's competition here
CHRA vs LICY Comparison May 2026
CHRA plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHRA stands at 20.3M. In comparison, LICY has a market cap of 29.9M. Regarding current trading prices, CHRA is priced at $5.96, while LICY trades at $0.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHRA currently has a P/E ratio of -0.15, whereas LICY's P/E ratio is -0.15. In terms of profitability, CHRA's ROE is +20.59%, compared to LICY's ROE of -0.41%. Regarding short-term risk, CHRA is less volatile compared to LICY. This indicates potentially lower risk in terms of short-term price fluctuations for CHRA.Check LICY's competition here
CHRA vs AMBI Comparison May 2026
CHRA plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHRA stands at 20.3M. In comparison, AMBI has a market cap of 24.4M. Regarding current trading prices, CHRA is priced at $5.96, while AMBI trades at $0.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHRA currently has a P/E ratio of -0.15, whereas AMBI's P/E ratio is -44.00. In terms of profitability, CHRA's ROE is +20.59%, compared to AMBI's ROE of -0.02%. Regarding short-term risk, CHRA is less volatile compared to AMBI. This indicates potentially lower risk in terms of short-term price fluctuations for CHRA.Check AMBI's competition here
CHRA vs QRHC Comparison May 2026
CHRA plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHRA stands at 20.3M. In comparison, QRHC has a market cap of 23.5M. Regarding current trading prices, CHRA is priced at $5.96, while QRHC trades at $1.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHRA currently has a P/E ratio of -0.15, whereas QRHC's P/E ratio is -1.53. In terms of profitability, CHRA's ROE is +20.59%, compared to QRHC's ROE of -0.36%. Regarding short-term risk, CHRA is less volatile compared to QRHC. This indicates potentially lower risk in terms of short-term price fluctuations for CHRA.Check QRHC's competition here
CHRA vs ENGS Comparison May 2026
CHRA plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHRA stands at 20.3M. In comparison, ENGS has a market cap of 18.4M. Regarding current trading prices, CHRA is priced at $5.96, while ENGS trades at $1.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHRA currently has a P/E ratio of -0.15, whereas ENGS's P/E ratio is -5.61. In terms of profitability, CHRA's ROE is +20.59%, compared to ENGS's ROE of +0.28%. Regarding short-term risk, CHRA is less volatile compared to ENGS. This indicates potentially lower risk in terms of short-term price fluctuations for CHRA.Check ENGS's competition here
CHRA vs AQMS Comparison May 2026
CHRA plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHRA stands at 20.3M. In comparison, AQMS has a market cap of 18.3M. Regarding current trading prices, CHRA is priced at $5.96, while AQMS trades at $5.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHRA currently has a P/E ratio of -0.15, whereas AQMS's P/E ratio is -0.35. In terms of profitability, CHRA's ROE is +20.59%, compared to AQMS's ROE of -2.52%. Regarding short-term risk, CHRA is less volatile compared to AQMS. This indicates potentially lower risk in terms of short-term price fluctuations for CHRA.Check AQMS's competition here
CHRA vs AWX Comparison May 2026
CHRA plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHRA stands at 20.3M. In comparison, AWX has a market cap of 10M. Regarding current trading prices, CHRA is priced at $5.96, while AWX trades at $2.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHRA currently has a P/E ratio of -0.15, whereas AWX's P/E ratio is 32.00. In terms of profitability, CHRA's ROE is +20.59%, compared to AWX's ROE of +0.01%. Regarding short-term risk, CHRA is less volatile compared to AWX. This indicates potentially lower risk in terms of short-term price fluctuations for CHRA.Check AWX's competition here
CHRA vs CHNR Comparison May 2026
CHRA plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHRA stands at 20.3M. In comparison, CHNR has a market cap of 5.5M. Regarding current trading prices, CHRA is priced at $5.96, while CHNR trades at $4.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHRA currently has a P/E ratio of -0.15, whereas CHNR's P/E ratio is -8.60. In terms of profitability, CHRA's ROE is +20.59%, compared to CHNR's ROE of -0.00%. Regarding short-term risk, CHRA is less volatile compared to CHNR. This indicates potentially lower risk in terms of short-term price fluctuations for CHRA.Check CHNR's competition here
CHRA vs CDTG Comparison May 2026
CHRA plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHRA stands at 20.3M. In comparison, CDTG has a market cap of 3.2M. Regarding current trading prices, CHRA is priced at $5.96, while CDTG trades at $0.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHRA currently has a P/E ratio of -0.15, whereas CDTG's P/E ratio is -2.33. In terms of profitability, CHRA's ROE is +20.59%, compared to CDTG's ROE of -0.01%. Regarding short-term risk, CHRA is less volatile compared to CDTG. This indicates potentially lower risk in terms of short-term price fluctuations for CHRA.Check CDTG's competition here
CHRA vs GWAV Comparison May 2026
CHRA plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHRA stands at 20.3M. In comparison, GWAV has a market cap of 3M. Regarding current trading prices, CHRA is priced at $5.96, while GWAV trades at $3.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHRA currently has a P/E ratio of -0.15, whereas GWAV's P/E ratio is 0.02. In terms of profitability, CHRA's ROE is +20.59%, compared to GWAV's ROE of -0.89%. Regarding short-term risk, CHRA is less volatile compared to GWAV. This indicates potentially lower risk in terms of short-term price fluctuations for CHRA.Check GWAV's competition here
CHRA vs DXST Comparison May 2026
CHRA plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHRA stands at 20.3M. In comparison, DXST has a market cap of 1.2M. Regarding current trading prices, CHRA is priced at $5.96, while DXST trades at $1.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHRA currently has a P/E ratio of -0.15, whereas DXST's P/E ratio is -3.68. In terms of profitability, CHRA's ROE is +20.59%, compared to DXST's ROE of -0.04%. Regarding short-term risk, CHRA is less volatile compared to DXST. This indicates potentially lower risk in terms of short-term price fluctuations for CHRA.Check DXST's competition here
CHRA vs ECOLW Comparison May 2026
CHRA plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHRA stands at 20.3M. In comparison, ECOLW has a market cap of 0. Regarding current trading prices, CHRA is priced at $5.96, while ECOLW trades at $5.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHRA currently has a P/E ratio of -0.15, whereas ECOLW's P/E ratio is N/A. In terms of profitability, CHRA's ROE is +20.59%, compared to ECOLW's ROE of +0.01%. Regarding short-term risk, CHRA and ECOLW have similar daily volatility (0.00).Check ECOLW's competition here
CHRA vs NES Comparison May 2026
CHRA plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHRA stands at 20.3M. In comparison, NES has a market cap of 0. Regarding current trading prices, CHRA is priced at $5.96, while NES trades at $2.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHRA currently has a P/E ratio of -0.15, whereas NES's P/E ratio is -1.32. In terms of profitability, CHRA's ROE is +20.59%, compared to NES's ROE of -0.29%. Regarding short-term risk, CHRA is less volatile compared to NES. This indicates potentially lower risk in terms of short-term price fluctuations for CHRA.Check NES's competition here
CHRA vs CVA Comparison May 2026
CHRA plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHRA stands at 20.3M. In comparison, CVA has a market cap of 0. Regarding current trading prices, CHRA is priced at $5.96, while CVA trades at $20.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHRA currently has a P/E ratio of -0.15, whereas CVA's P/E ratio is N/A. In terms of profitability, CHRA's ROE is +20.59%, compared to CVA's ROE of -0.08%. Regarding short-term risk, CHRA is less volatile compared to CVA. This indicates potentially lower risk in terms of short-term price fluctuations for CHRA.Check CVA's competition here
CHRA vs SMED Comparison May 2026
CHRA plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHRA stands at 20.3M. In comparison, SMED has a market cap of 0. Regarding current trading prices, CHRA is priced at $5.96, while SMED trades at $8.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHRA currently has a P/E ratio of -0.15, whereas SMED's P/E ratio is 36.46. In terms of profitability, CHRA's ROE is +20.59%, compared to SMED's ROE of +0.34%. Regarding short-term risk, CHRA is less volatile compared to SMED. This indicates potentially lower risk in terms of short-term price fluctuations for CHRA.Check SMED's competition here
CHRA vs ECOL Comparison May 2026
CHRA plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHRA stands at 20.3M. In comparison, ECOL has a market cap of 0. Regarding current trading prices, CHRA is priced at $5.96, while ECOL trades at $47.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHRA currently has a P/E ratio of -0.15, whereas ECOL's P/E ratio is N/A. In terms of profitability, CHRA's ROE is +20.59%, compared to ECOL's ROE of +0.01%. Regarding short-term risk, CHRA is less volatile compared to ECOL. This indicates potentially lower risk in terms of short-term price fluctuations for CHRA.Check ECOL's competition here